Netupitant/Palonosetron Hydrochloride

奈妥吡坦/盐酸帕洛诺司琼

Report date: 2026/04/03 20:03:44

Base Information

Drug NameNetupitant/Palonosetron Hydrochloride
Drug Alias NamePalonosetron Hydrochloride/Netupitant奈妥吡坦盐酸帕洛诺司琼盐酸帕洛诺司琼/奈妥吡坦Palonosetron Hydrochloride and Netupitant盐酸帕洛诺司琼奈妥吡坦 +[15] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonistsNeurokinin 1 receptor antagonists
TargetsSerotonin 3 (5-HT3) receptorNeurokinin 1 receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[4] 
Global Approved IndicationsChemotherapy-induced nausea and vomiting
Approved Indications in ChinaChemotherapy-induced nausea and vomiting
Original Approved Country/TerritoryUnited States
Original Approved Date2014/10/10
Country/TerritoryUnited StatesTaiwanPoland +[9] 
CombinationsYes Palonosetron HydrochlorideNetupitant
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHelsinn
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdEsteve Healthcare SLKnight Therapeutics +[7] 
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA04AA
Related LinksWikipediaKEGG